Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant
نویسندگان
چکیده
منابع مشابه
Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
PURPOSE Preformed circulating donor-specific antibodies (DSAs) immunologically challenge vascular endothelium and the bile duct. However, the liver is an immune-tolerant organ and can avoid immunological challenges. This study was undertaken to analyze the effects of DSAs after adult living donor liver transplantation (LDLT). METHODS We retrospectively reviewed 219 LDLT patients' records trea...
متن کاملEffects of infection on post-transplant outcomes: living versus deceased donor liver transplants
Introduction Post-transplant infections have been studied widely but data on comparisons of deceased donor liver transplants (DDLT) and living donor liver transplants (LDLT), type and timings of infections, and their relations to outcomes are not explored. Material and methods We analysed data from 612 participants of the Adult-to-Adult Living Donor Liver Transplantation Study (A2ALL), a retr...
متن کاملNew Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database
New onset diabetes after transplantation (NODAT) occurs less frequently in living donor liver transplant (LDLT) recipients than in deceased donor liver transplant (DDLT) recipients. The aim of this study was to compare the incidence and predictive factors for NODAT in LDLT versus DDLT recipients. The Organ Procurement and Transplant Network/United Network for Organ Sharing database was reviewed...
متن کاملHepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
UNLABELLED Donor factors influence hepatitis C virus (HCV) disease severity in liver transplant (LT) recipients. Living donors, because they are typically young and have short cold ischemic times, may be advantageous for HCV-infected patients. Among HCV-infected patients in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) surviving >90 days and followed for a median 4....
متن کاملA deceased-donor liver transplant program must precede a living-donor program.
Liver transplantation is now a well-established therapeutic procedure for patients suffering from endstage liver disease. In the last few years, partly as a response to increasing demand for organs and partly as a result of improved technical expertise, livingrelated liver transplantation (LRLT) has emerged as an option to the traditional deceased-donor trans plant procedure. In most countries...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Transplantation
سال: 2018
ISSN: 1600-6135
DOI: 10.1111/ajt.14709